CLINICAL AND ANAMNESTIC CHARACTERISTICS AND REPRODUCTIVE FUNCTION OF WOMEN WITH ADENOMYOSIS

Authors
E.Kh. Khushvakhtova D.M. Akilova
Job:
Tajik Research Institute of Obstetrics, Gynecology and Perinatology, Dushanbe, Tajikistan
DOI:
10.65197/3106-4035-2025-1-3-61-78

Annotation

Resume.Adenomyosis is one of the leading gynecological pathologies, significantly impacting the quality of life and reproductive health of women. A comprehensive study of the clinical and anamnestic characteristics of patients with different treatment approaches remains a pressing issue.

Goal. To conduct an indepth analysis and provide a comparative clinical and anamnestic characteristic, as well as an assessment of the reproductive function of women with adenomyosis depending on the management tactics used (conservative therapy, surgery, observation) and the clinical course of the disease.

Material and methods. A prospective, controlled study was conducted involving 153 women. The main group consisted of 127 patients with a confirmed diagnosis of adenomyosis, who were divided into 4 subgroups: Group I (n=51)women treated with the combined oral contraceptive Belara and Indol; Group II (n=27)patients who received the Mirena IUD; Group III (n=37) included patients undergoing hysterectomy for adenomyosis resistant to conservative therapy; Group IV (n=12) included asymptomatic women undergoing followup. The control group (V) consisted of 26 somatically and gynecologically healthy women. A detailed analysis of sociodemographic data, personal and disease history, menstrual and reproductive functions was performed, as well as a quality of life assessment using the EHP5+6 questionnaire.

Results. Patients with adenomyosis were found to have a complicated medical history. A high frequency of menstrual dysfunction was observed, particularly early (27.0% in Group III) and late (35.1% in Group III) menarche (p<0.05). Various menstrual cycle disorders, including hyperpolymenorrhea (24.3% in Group III) and acyclic bleeding (up to 25% in Group IV), were recorded significantly more frequently than in the control group. Reproductive function was characterized by a high rate of spontaneous abortions (over 30%) and secondary infertility (up to 27.2% in Group IV). High comorbidity was observed with chronic endometritis (up to 51.8% in Group II, p < 0.05), cervical pathologies, and extragenital diseases, especially anemia (48.6% in Group III). The clinical picture was manifested by severe pain syndrome (up to 94.5% in Group III), which led to a significant decrease in quality of life, emotional distress (75.6%), and high anxiety about treatment failure (94.5%) in Group III patients.

Conclusion. Women with adenomyosis represent a clinically heterogeneous group with a significant medical and gynecological history, as well as significant menstrual and reproductive dysfunction. The severity of clinical manifestations directly correlates with a decreased quality of life, necessitating the development of differentiated approaches to the care of this patient population.

Keywords

Adenomyosis endometriosis reproductive function menstrual cycle quality of life hysterectomy conservative therapy clinical characteristics.

Full text

The article is in PDF format

List of literature

  1. 1. Dason E.S., Maxim M., Sanders A., Papillon-Smith J., Ng D., Chan C., Sobel M. Guideline No. 437: diagnosis and management of adenomyosis. Journal of Obstetrics and Gynaecology Canada. 2023; 45(6): 417-429.
  2. 2. Roop S., Patel S., Zhang M., Tran V., Boucher L.M., Reinhold C., Pelage J.P. Uterine artery embolization for adenomyosis: a review of imaging, techniques, complications and outcomes. Current Obstetrics and Gynecology Reports. 2023; 12(3): 186-197.
  3. 3. 3Khan K.N., Fujishita A., Mori T. Pathogenesis of human adenomyosis: current understanding and its association with infertility. Journal of clinical medicine. 2022; 11(14): 4057.
  4. 4. Martire F.G., d’Abate C., Schettini G., Cimino G., Ginetti A., Colombi I., Lazzeri L. Adenomyosis and adolescence: a challenging diagnosis and complex management. Diagnostics. 2024; 14(21): 2344.
  5. 5. Шарипов Г.Н., Исмоилов М.М., Шаймонов А.Х., Саидов М.С., Исмоилов Э.Х. Варикозная болезнь вен малого таза, поликистоз яичников и другая сопутствующая патология у женщин с трубной беременностью. Вестник Смоленской государственной медицинской академии. 2019; 18(1): 99- 102.
  6. 6. Selntigia A., Molinaro P., Tartaglia S., Pellicer A., Galliano D., Cozzolino M. Adenomyosis: an update concerning diagnosis, treatment, and fertility. Journal of Clinical Medicine. 2024; 13(17): 5224.
  7. 7. Vercellini P., Bandini V., Vigano P., Di Stefano G., Merli C.E.M., Somigliana E. Proposal for targeted, neo-evolutionaryoriented, secondary prevention of earlyonset endometriosis and adenomyosis. Part I: pathogenic aspects. Human Reproduction. 2024; 39(1): 1-17.
  8. 8. Ng C.H., Michelmore A.G., Mishra G.D., Montgomery G.W., Rogers P.A., Abbott J.A. Establishing the Australian National Endometriosis Clinical and scientific trials (NECST) registry: a protocol paper. Reproduction and Fertility. 2023; 4(2): e230014 https://doi.org/10.153
  9. 9. Moldassarina R.S. Modern view on the diagnostics and treatment of adenomyosis. Archives of Gynecology and Obstetrics. 2023; 308(1): 171-181.
  10. 10. Younes G., Tulandi T. Conservative surgery for adenomyosis and results: a systematic review. Journal of minimally invasive gynecology. 2018; 25(2): 265- 276.
  11. 11. Becker C.M., Bokor A., Heikinheimo O., Horne A., Jansen F., Kiesel L., Vermeulen N. ESHRE guideline: endometriosis. Human reproduction open. 2022; 2022(2): hoac009.
  12. 12. Bourdon M., Oliveira J., Marcellin L., Santulli P., Bordonne C., Maitrot Mantelet L., Chapron C. Adenomyosis of the inner and outer myometrium are associated with different clinical profiles. Human Reproduction. 2021; 36(2): 349-357.
  13. 13. Chapron C., Vannuccini S., Santulli P., Abrão M.S., Carmona F., Fraser I.S., Petraglia F. Diagnosing adenomyosis: an integrated clinical and imaging approach. Human reproduction update. 2020; 26(3): 392-411.
  14. 14. Rossi M., Vannuccini S., Capezzuoli T., Fambrini M., Vannuzzi V., Donati C., Petraglia F. Mechanisms and pathogenesis of adenomyosis. Current Obstetrics and Gynecology Reports. 2022; 11(2): 95-102.
  15. 15. Подзолкова Н.М., Фадеев И.Е., Масс Е.Е., Полетова Т.Н., Сумятина Л.В., Денисова Т.В. Неинвазивная диагностика и консервативная терапия эндометриоза. Гинекология. 2022; 24(3): 167-173.
  16. 16. Подзолкова Н.М., Фадеев И.Е., Масс Е.Е., Полетова Т.Н., Сумятина Л.В., Денисова Т.В. Неинвазивная диагностика и консервативная терапия эндометриоза. Гинекология. 2022; 24(3): 167-173.
  17. 17. Щукина Н.А., Буянова С.Н., Бабунашвили Е.Л., Земскова Н.Ю., Глебов Т.А. Современные подходы к лечению и отечественные рекомендации). Rossiiskii Vestnik Akushera-Ginekologa. 2022; 22(2): 119 124. https://doi. org/10.17116/rosakush202222021119
  18. 18. Оразов М.Р., Краснопольская К.В., Михалёва Л.М., Муллина И.А. Взгляд на патогенетические механизмы развития гиперпластических процессов эндометрия. Трудный пациент. 2021; 19(3): 35-38.
  19. 19. Адамян Л.В., Соколов А.Д., Аветисян Д.С., Шаповаленко Р.А. Современные методы диагностики аденомиоза: систематический обзор. Пробле
Information
Language

English

License

CC BY 4.0

Category

OBSTETRICS AND GYNECOLOGY

FINANCING

There was no financial support.

CONFLICT OF INTEREST

The authors declare no conflict of interest.

INFORMATION ABOUT THE AUTHORS:

*Khushvakhtova Ergashoy Khushvakhtovna – Doctor of Medical Sciences, Associate Professor, Leading Researcher Tajik Research Institute of Obstetrics, Gynecology and Perinatology, Dushanbe, Tajikistan. E-mail: hushvaxtova@mail.ru https://orcid.org/0000-0002-3851-2736 Akilova Dilfuza Muzafarovna – researcher Tajik Research Institute of Obstetrics, Gynecology and Perinatology, Dushanbe, Tajikistan. E-mail:akilova_dilfuza@mail.ru https://orcid.org/0009-0002-3855-5864

*Correspondence address.